Valerie Sampson also spent more than one year at WuXi Advanced Therapies, one of the biggest biotech employers in ...

Shares of DuPont de Nemours Inc. DD inched 0.48% higher to $77.25 Tuesday, on what proved to be an all-around positive ...

Jenna Pellicori-Curry spent around $40,000 out-of-pocket on medical treatments to conceive her first child, who is now 3 ...

The expansion plans call for a bigger ER, more surgery suites and a bigger orthopedics department, among other changes.

The new building renovations, which are expected to be completed by mid-2026, will "preserve the building’s core ...

Shares of DuPont de Nemours Inc. DD slipped 0.52% to $76.88 Monday, on what proved to be an all-around favorable trading ...

According to the retraction notices published in JVS-Vascular Science and Oncotarget, Valerie Sampson admitted to ...

Plus, a Philly judge has ordered a retrial of the $45 million malpractice verdict against Temple, and a Bucks County doctor ...

Nemours Children’s Health has plans to significantly expand its footprint in Central Florida with a $300 million expansion of ...

DuPont de Nemours (NYSE:DD – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” ...

DuPont de Nemours (DD) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...

In the latest quarter, 6 analysts provided ratings for DuPont de Nemours DD, showcasing a mix of bullish and bearish ...